PVP Ventures
24.07
-0.45(-1.84%)
Market Cap₹626.79 Cr
PE Ratio-67.56
IndustryRealty
Company Performance:
1D-1.84%
1M-11.64%
6M-21.60%
1Y+4.43%
5Y+318.61%
View Company Insightsright
More news about PVP Ventures
23Feb 26
PVP Ventures Limited Announces Q3 FY26 Results and Board Changes
PVP Ventures Limited reported its Q3 FY26 financial results and announced the resignation of Mrs. P.J. Bhavani as Non-Executive Non-Independent Director due to personal reasons. The company maintains a significant loan portfolio with Rs. 21,843.49 Lakhs outstanding to New Cyberabad City Projects Private Limited, generating substantial interest income of Rs. 261.91 Lakhs for the quarter.
 no imag found
05Feb 26
PVP Ventures Limited Schedules Board Meeting on February 12, 2026 for Q3FY26 Financial Results
PVP Ventures Limited has scheduled a board meeting for February 12, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The meeting will be conducted via video conferencing in compliance with regulatory requirements. The company has implemented trading window restrictions for directors, designated persons, and insiders, which will remain in effect until 48 hours after the financial results publication, as per SEBI insider trading regulations.
 no imag found
31Jan 26
PVP Ventures' Material Subsidiary Files Compounding Application with NCLT Chennai
PVP Ventures Limited has disclosed that its material subsidiary, Biohygea Global Private Limited, has filed a compounding application before NCLT Chennai for certain past non-compliances under the Companies Act, 2013. The matter remains sub-judice with penalty quantum to be determined upon disposal. The company has stated no material impact on operations or financial position is expected from this development.
 no imag found
31Jan 26
PVP Ventures Limited Sets Record Date for NCD Interest Payment and Partial Redemption
PVP Ventures Limited has fixed February 5, 2026 as the record date for interest payment and partial redemption of principal for its Non-Convertible Debentures, with payments scheduled for February 6, 2026. The announcement covers two ISIN series and has been communicated to stock exchanges in compliance with SEBI regulations.
 no imag found
22Jan 26
PVP Ventures Appoints Dileep Badey as Additional Director and Reconstitutes Board Committees
PVP Ventures Limited appointed Mr. Dileep Badey as Additional Director (Executive) effective January 22, 2026, subject to shareholder approval. Mr. Badey, the company's Head – Projects with over 15 years of experience in engineering and real estate development, will serve until the next General Meeting or three months from appointment. The Board also reconstituted three committees - Audit, Investment, and Non-Convertible Debenture committees - to include the new director, ensuring enhanced governance structure across key functions.
 no imag found
08Dec 25
PVP Ventures Appoints New Statutory Auditor and CFO Resigns
PVP Ventures Limited's Board has appointed M/s. CNGSN Associates LLP as the new Statutory Auditors, replacing M/s. PSDY Associates, subject to shareholder approval. The company's CFO, Mr. K. Anand Kumar, has resigned effective December 8, 2025, to pursue other opportunities.
 no imag found
04Nov 25
PVP Ventures Secures 33.24% Stake in 7Med India, Marks Entry into Healthcare Sector
PVP Ventures Limited has completed the first phase of its strategic acquisition of 7Med India Private Limited, acquiring a 33.24% stake. The company plans to increase its ownership to 50.62% by August 28, 2026, with a total estimated investment of INR 127.00 crores. This move marks PVP Ventures' entry into the healthcare industry, specifically the renal care sector. 7Med India is among the top five organized players in India's renal care sector and reported an EBITDA of approximately INR 10.00 crore for the current financial year.
 no imag found
25Oct 25
PVP Ventures CEO Arjun Ananth Steps Down, Company Seeks Global Talent for Replacement
Arjun Ananth, CEO and Whole Time Director of PVP Ventures Limited, has resigned effective October 25, 2025. The company is in advanced discussions with global talent from reputed institutions to enhance its senior leadership and strengthen the Board. PVP Ventures assures compliance with SEBI regulations and plans to announce new appointments shortly.
 no imag found
25Sept 25
PVP Ventures Appoints ARS & Associates as Secretarial Auditor for Five-Year Term
PVP Ventures Limited has appointed M/s. ARS & Associates Company Secretaries LLP as its Secretarial Auditor for a five-year term from 2025-26 to 2029-30. The appointment was approved by shareholders at the company's 34th AGM on September 25, 2025, in compliance with SEBI regulations. ARS & Associates, established in 2016, is a peer-reviewed firm with expertise in secretarial and compliance services. The firm has no association with PVP Ventures' directors, ensuring independence in their role.
 no imag found
05Sept 25
PVP Ventures Reports Q2 FY2021 Losses, Announces Leadership Changes and AGM Date
PVP Ventures Ltd disclosed Q2 and H1 FY2021 results, reporting net losses of Rs 600.08 lakhs and Rs 1,228.79 lakhs respectively. The company announced leadership changes, including the resignation of CFO T N Madan and appointment of Karthikeyan as the new CFO. The Board also accepted the resignation of statutory auditor Brahmayya & Co., appointing Sundaram & Srinivasan as replacement. PVP Ventures faces financial challenges with unpaid debenture obligations of Rs 8,305.94 lakhs and current liabilities exceeding current assets by Rs 11,981.62 lakhs. Auditors raised concerns about investment recoverability, corporate guarantees, and the company's ability to continue as a going concern.
 no imag found
28Aug 25
PVP Ventures Acquires Majority Stake in Healthcare Platform 7Med India
PVP Ventures, a diversified company, has acquired a 41.2% stake in 7Med India Pvt. Ltd., a renal care and healthcare platform. This acquisition makes PVP Ventures the majority shareholder in 7Med India, marking a significant expansion into the healthcare sector. The move represents a strategic diversification for PVP Ventures, positioning it to play an active role in the growing healthcare industry, particularly in specialized renal care services.
 no imag found
25Jul 25
Madras High Court Quashes GST Demand Notices for PVP Ventures in Joint Development Case
The Madras High Court has ruled that no GST is leviable on landowners in joint development arrangements, quashing GST demand notices issued to PVP Ventures Limited. The court set aside demand notices dated July 22, 2024, and January 17, 2025, related to a joint development agreement between PVP Ventures and a developer. This ruling clarifies the GST liability position for landowners in such arrangements and could have significant implications for the real estate sector across India.
 no imag found
09Jun 25
SEBI Seeks Additional Clarifications from PVP Ventures
The Securities and Exchange Board of India (SEBI) has requested PVP Ventures Limited to provide additional clarifications and supporting documents. The specific nature of the clarifications sought remains undisclosed. This regulatory inquiry could potentially impact investor confidence and may require prompt action from the company to gather and submit the required information. PVP Ventures has not yet released any public statement regarding the nature of the clarifications or their response timeline.
 no imag found
23Apr 25
PVP Ventures Expands Healthcare Portfolio with Strategic Acquisitions
PVP Ventures Limited has acquired a 52% stake in Biohygea Global (Medilabs) for 70 million rupees and a 56% stake in Optimus Oncology Private Limited for 547.30 million rupees. These acquisitions mark PVP's transition from real estate to healthcare services, focusing on Tier 2 and 3 cities in India. The company expects to generate over 20 billion rupees from its real estate developments in the next six years to fund healthcare growth. Additionally, PVP appointed B. Vignesh Ram as Company Secretary & Compliance Officer.
 no imag found
23Apr 25
PVP Ventures Expands into Oncology Care with 56% Stake Acquisition in Optimus Oncology
PVP Ventures Limited is acquiring a 56.01% stake in Optimus Oncology Private Limited for Rs 54.73 crore, marking its entry into the healthcare sector. Optimus Oncology, founded in 2018, specializes in radiation therapy for cancer care. The acquisition aligns with PVP Ventures' strategy to build a technology-centric healthcare services platform. The deal is expected to close within 90 days from April 23, 2025. Separately, PVP Ventures appointed Mr. B. Vignesh Ram as Company Secretary & Compliance Officer.
 no imag found
PVP Ventures
24.07
-0.45
(-1.84%)
1 Year Returns:+4.43%
Industry Peers
DLF
529.20
(+1.33%)
Lodha Developers
710.25
(+2.04%)
Phoenix Mills
1,554.70
(+1.93%)
Oberoi Realty
1,519.90
(+0.86%)
Godrej Properties
1,584.70
(+5.07%)
Brigade Enterprises
690.85
(+0.48%)
Anant Raj
455.55
(+0.84%)
Sobha
1,220.00
(+5.46%)
Signatureglobal
780.30
(+4.11%)